Deals Virax raises $3m for Pathway takeover Virax Holdings has completed a $3 million equity placement to sophisticated investors to support its acquisition last week of Pathway Oncology. 25 Mar 2014
Deals Virax takeover clinches anti-cancer drug Virax Holdings has agreed to acquire Pathway Oncology in a reverse takeover which will see the Australia-listed company gain control of a global licence for emerging anti-cancer technology. 17 Mar 2014
